In QuotedData’s morning briefing 10 February 2021 –
- Syncona, a leading healthcare company focused on founding, building and funding global leaders in life science, made note of the news that its portfolio company, Autolus Therapeutics announced the pricing of its underwritten public offering in the United States of 14,285,715 American Depositary Shares (“ADSs”) representing 14,285,715 ordinary shares, at a public offering price of $7.00 per ADS, for total gross proceeds of approximately $100m. Martin Murphy, CEO of Syncona’s manager, said, “Our strategy is to work closely with our portfolio companies and fund them over the long-term as they seek to take product candidates to approval. We are excited by the potential of Autolus’ AUTO1 product candidate for the treatment of adult acute lymphoblastic leukaemia to become a stand-alone treatment for patients. We believe the business is well-positioned to deliver this programme through its pivotal trial and progress its pipeline of next-generation T-cell therapies.”
- Riverstone, the manager of Riverstone Energy (RSE), announced the signing of an agreement for RSEto purchase $10m of Decarbonization Plus Acquisition Corporation (NASDAQ: DCRB) common stock in a private placement transaction at $10 per share.
- Empiric Student Property has revealed occupancy across its portfolio has fallen to 65% from 70% in October 2020. It added that it couldn’t give full-year revenue guidance “until there is greater certainty on when the current national lockdown will end, as well as students and universities intentions for the remainder of the current academic term and year”.
We also have annual results from BlackRock Throgmorton.